Featured News
620NewsAdvanced Energy’s 4100T optical fiber thermometer improves temperature accuracy and control in advanced semiconductor processes
With better measurement accuracy and higher read rate, the 4100T multi-channel, non-contact optical fiber thermometer enables easy upgrade from market-leading OR4000T DENVER,...
- 754News
CIFI’s ESG rating further upgraded to ‘BBB’ by MSCI
HONG KONG SAR – Media OutReach – 24 November 2021 – CIFI Holdings (Group) Co. Ltd. (“CIFI” or the “Group”, HKEx stock code: 884), a leading...
- 582Wire Stories
Best’s Market Segment Report: AM Best Maintains Stable Outlook on Taiwan’s Non-Life Insurance Market
HONG KONG–(BUSINESS WIRE)–#insurance—AM Best is maintaining a stable market segment outlook on Taiwan’s non-life insurance segment, citing robust underwriting and investment performance...
- 577Wire Stories
VeriSilicon Image Signal Processor IP Achieved ISO 26262 Automotive Functional Safety Certification
The awarded certificate accelerates VeriSilicon’s strategic deployment in autonomous driving and the automotive segment in general SHANGHAI–(BUSINESS WIRE)–#AI–VeriSilicon (688521.SH), a leading Silicon...
- 673News
DHL Supply Chain is entrusted by GE Healthcare Japan with logistics operations to optimize healthcare service parts logistics
DHL Supply Chain opens five new logistics centers in Japan to meet the increasing demand of Service Parts for healthcare equipment. TOKYO,...
- 688Wire Stories
Hagens Berman: Sun and Ranbaxy Facing January Trial as Federal Judge Denies Summary Judgment in Generic Drug Overpricing Lawsuit
Attorneys will take antitrust case to trial in January 2022 BOSTON–(BUSINESS WIRE)–#antitrust–Yesterday, a federal judge denied all motions for summary judgment in...
- 652Wire Stories
Takeda’s LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant Cytomegalovirus (CMV), Refractory (With or Without Genotypic Resistance) to Conventional Antiviral Therapies
– In the Phase 3 SOLSTICE study, more than twice the proportion of adult transplant recipients with refractory or resistant (R/R) CMV...
- 604Wire Stories
EBR Systems Raises AU$110M in Initial Public Offering on the Australian Securities Exchange (ASX)
EBR Systems’ WiSE™ CRT System is world’s first and only wireless endocardial (inside the heart) left ventricle pacing system for heart failure...
- 608Wire Stories
BeiGene Announces Approval of BRUKINSA (zanubrutinib) in the European Union for Treatment of Adults with Waldenström’s Macroglobulinemia
EU approval follows recent approvals for BRUKINSA including U.S., China, Brazil, and Canada The approval is based on Phase 3 ASPEN head-to-head...
- 605Wire Stories
Republic of Palau Partners with Ripple to Develop Digital Currency Strategy
Palau to explore using the XRP Ledger to create world’s first government-issued national stablecoin SAN FRANCISCO & NGERULMUD, Palau–(BUSINESS WIRE)–Ripple, the leading...
- 645Wire Stories
Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial in China of GlycoMimetics’ Uproleselan for the Treatment of AML
ROCKVILLE, Md.–(BUSINESS WIRE)–GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that Apollomics has dosed the first patient in China in a Phase 3 clinical...
